Farm Agency Tweak: More Forms for Eco-Watching
Published Date: 9/3/2026
Notice
Summary
In accordance with the Paperwork Reduction Act of 1995, this notice announces the Animal and Plant Health Inspection Service's intention to request a revision to and extension of approval of an information collection associated with environmental monitoring.
Analyzed Economic Effects
1 provisions identified: 0 benefits, 1 costs, 0 mixed.
Environmental Monitoring Reporting Burden
If you are a grower, pesticide applier, or State department of agriculture staff, APHIS will continue collecting environmental monitoring information using an APHIS form for an additional 3 years. APHIS estimates 11 respondents will file 3 responses each per year (31 responses total), with an average burden of 0.23 hours per response and a total annual burden of 7.0 hours. Comments are due November 2, 2026.
Personalized for You
How does this regulation affect your finances?
Personalize government policy and PRIA will tell you what this federal register document means for your household, plus every other regulation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-18021, Notice of Request for Revision to and Extension of Approval of an Information Collection; Irradiation Treatment; Location of Facilities in the Southern United States
In accordance with the Paperwork Reduction Act of 1995, this notice announces the Animal and Plant Health Inspection Service's intention to request a revision to and extension of approval of an information collection associated with the regulations for the location of irradiation treatment facilities in the United States.
2026-17596, State University of New York College of Environmental Science and Forestry: Determination of Nonregulated Status for Blight-Tolerant Darling 54 American Chestnut (Castanea dentata)
We are advising the public of our determination that Darling 54 American Chestnut (Castanea dentata), which was developed using genetic engineering for tolerance to the fungal pathogen, Cryphonectria parasitica, is no longer considered regulated. Our determination is based on our evaluation of information and data submitted by the State University of New York College of Environmental Science and Forestry in its petition for a determination of nonregulated status, available scientific data, a plant pest risk assessment, and public comments received in response to previous notices announcing the availability of the petition for nonregulated status and a draft plant pest risk assessment. This notice announces the availability of our written determination and supporting documents.
2026-16844, Notice of Request for Revision to and Extension of Approval of an Information Collection; Animal Care; Standards for Birds Not Bred for Use in Research Under the Animal Welfare Act
In accordance with the Paperwork Reduction Act of 1995, this notice announces the Animal and Plant Health Inspection Service's intention to request a revision to and extension of approval of an information collection associated with the Animal Welfare Act regulations for the humane handling, care, treatment, and transportation of birds not bred for use in research by dealers, exhibitors, operators of auction sales, research facilities, carriers and intermediate handlers.
2026-15845, National Poultry Improvement Plan and Auxiliary Provisions
We are proposing to amend the regulations governing the National Poultry Improvement Plan (NPIP). These amendments would, among other things, clarify existing provisions of the regulations, fix editorial errors, and align the regulations more closely with current producer practices. These proposed changes were voted on and approved by the voting delegates at the NPIP's 2024 National Plan Conference.
2026-15856, Notice of Request for Approval of a New Information Collection; National Animal Health Monitoring System; Poultry 2027 Upland Gamebird and Duck Study
The USDA’s Animal and Plant Health Inspection Service is planning a new study in 2027 to learn more about upland gamebirds and ducks. This study will collect important info from poultry owners and farmers to help keep birds healthy. If you’re involved with these birds, get ready to share some data by October 5, 2026, and help shape the future of animal health!
2026-15876, Bayer/Monsanto: Determination of Nonregulated Status for MON 87429 Maize Genetically Engineered for Dicamba, Glufosinate, Quizalofop, and 2,4-Dichlorophenoxyacetic Acid (2,4-D) Resistance With Tissue-Specific Glyphosate Resistance Facilitating the Production of Hybrid Maize Seed
The USDA says Bayer/Monsanto’s MON 87429 maize, a special corn engineered to resist several herbicides and help make hybrid seeds, is no longer regulated starting August 5, 2026. This means farmers and seed producers can grow and sell this corn more easily without extra government rules. It’s a big win for agriculture, helping farmers protect crops and boost seed production without extra costs or delays.
Previous / Next Documents
Previous: 2026-18021, Notice of Request for Revision to and Extension of Approval of an Information Collection; Irradiation Treatment; Location of Facilities in the Southern United States
In accordance with the Paperwork Reduction Act of 1995, this notice announces the Animal and Plant Health Inspection Service's intention to request a revision to and extension of approval of an information collection associated with the regulations for the location of irradiation treatment facilities in the United States.
Next: 2026-18023, Determination That PHENAPHEN WITH CODEINE NO. 3 (Acetaminophen; Codeine Phosphate) Oral Capsules, 325 Milligrams and 30 Milligrams, and PHENAPHEN WITH CODEINE NO. 4 (Acetaminophen; Codeine Phosphate) Oral Capsules, 325 Milligrams and 60 Milligrams, Were Not Withdrawn From Sale for Reasons of Safety or Effectiveness
The Food and Drug Administration (FDA or Agency) has determined that PHENAPHEN WITH CODEINE NO. 3 (acetaminophen; codeine phosphate) oral capsules, 325 milligrams (mg) and 30 mg, and PHENAPHEN WITH CODEINE NO. 4 (acetaminophen; codeine phosphate) oral capsules, 325 mg and 60 mg, were not withdrawn from sale for reasons of safety or effectiveness. This determination will allow FDA to approve abbreviated new drug applications (ANDAs) for PHENAPHEN WITH CODEINE NO. 3 (acetaminophen; codeine phosphate) oral capsules, 325 mg and 30 mg, and PHENAPHEN WITH CODEINE NO. 4 (acetaminophen; codeine phosphate) oral capsules, 325 mg and 60 mg, if all other legal and regulatory requirements are met.